Pressrelease – Lund, March 30th, 2026 – Hamlet BioPharma presented at the Financial Stockholm event on March 26, 2026

Hamlet BioPharma AB, an innovative pharmaceutical company developing new therapies for cancer and infections, announces that the company presented its latest advances at the Financial Stockholm event on March 26, 2026.

Financial Stockholm is a central meeting place for companies and investors who want to stay up to date on the latest trends in the stock market. The event attracts both professional players and private investors from all over Sweden.

For more information, please contact:

Catharina Svanborg, Chairman of the Board, Hamlet BioPharma, +46-709 42 65 49
catharina.svanborg@hamletpharma.com

Jakob Testad, CEO, Hamlet BioPharma, +46-708 48 42 10
jakob.testad@hamletbiopharma.com

www.hamletbiopharma.com